SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615219-17-000025
Filing Date
2017-04-12
Accepted
2017-04-12 14:10:34
Documents
2
Period of Report
2017-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_149202061927552.html 3  
1 FORM 3 wf-form3_149202061927552.xml 3 1714
2 MCVICAR POWER OF ATTORNEY mcvicarpowerofattorney.htm EX-24 3287
  Complete submission text file 0001615219-17-000025.txt   6415
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421
Business Address
McVicar William K. (Reporting) CIK: 0001634368 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 17757750